Welcome to factory-direct-buy
Chongqing Saipu Nasi Technology Co., Ltd
Chongqing Saipu Nasi Technology Co., Ltd
Sign in or Join Free Now!

Manufacturer Video

Contact Us

Street Address
North New District
Country/Region
China (Mainland)/Chongqing
Telephone

86-023-13048470428

Pharmaceutical Raw Material Powder Dapoxetine CAS No: 119356-77-3
Pharmaceutical Raw Material Powder Dapoxetine CAS No: 119356-77-3
  • >= 1  Gram US $1.000
Supply Ability:
1000000 Gram/Grams per Week
Port:
Guangdong /China
Email:
Quantity:
Gram
  • Product Detils
  • Company Profile
Quick Details
Place of Origin:
China (Mainland)
Brand Name:
119356-77-3
Model Number:
Dapoxetine
Packaging & Delivery

foil bag, barrel or as your inquiry
Product Description

Pharmaceutical Raw Material Powder Dapoxetine CAS No: 119356-77-3

Basic Info:

Product name: Dapoxetine

CAS No: 119356-77-3

Purity: 98%

Appearance: White powder, odorless, slightly sweet, soluble in water and alcohol.


HS code:3002100000

Reference FOB Price:$1/g


MOQ:10g


Package:1kg/foil bag or as your inquiry

Shelf life:2 years


Shippig: DHL, EMS, FedEx, UPS

Usage: can be used as pharmaceutical material, Dapoxetine improves erectile function significantly, possibly increase testosterone through increased sexual activity, and it is very safe.


Skype/E-mail : summer at chembj.com

Product Description:


Dapoxetine,  (among and other brands) is the first compound developed specially for the treatment of premature ejaculation (PE) for men at th age of 18-64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin's action at the post synaptic cleft, so as to delay ejaculation.. As a member of selective serotonin reuptake inhibitor (SSRI) family, Dapoxetine was initially created as an antidepressant. However, unlike other SSRIs, Dapoxetine is absorbed and eliminated rapidly in the body. Its fast response makes it suitable for the treatment of PE but not as an antidepressant.


Due to the lack of specific approval treatment for PE in the US and some other countries, other SSRIs such as Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, and Citalopram have been used as clinical drugs to treat PE. Waldinger's meta analysis shows that the use of these conventional antidepressants increases IELT from two to nine times above base line in comparison of three to eight times when Dapoxetine is used. 


However, these SSRIs must be taken daily in order to achieve meaningful efficacy, and the long half-life increases the risk of the drug accumulation and as a consequence an increased adverse effects such as decreasing sexual libido and causing erectile dysfunction. Dapoxetine, on the other hand, is a fast-acting SSRI. It is rapidly absorbed and eliminated from the body within a few hours. This favorable pharmacokinetics minimizes the risk of the drug's accumulation in the body, and therefore reducing side effects. 


Product Application:


Dapoxetine (dapoxetine) as a new fast SSRI, a short half life, a selective 5 - HT reuptake inhibitor (SSRI), for the treatment of premature ejaculation and erectile dysfunction. Dapoxetine is a selective 5 - HT reuptake inhibitor (SSRI), such drugs widely used to treat depression and related affective disorders. 


Randomized, double blind, placebo-controlled trials have confirmed the efficacy of dapoxetine for the treatment of PE. Different dosage has different impacts on different type of PE. Dapoxetine 60 mg significantly improves the mean intravaginal ejaculation latency time (IELT) compared to that of dapoxetine 30 mg in men with lifelong PE, but there is no difference in men with acquired PE. Dapoxetine, given 1-3 hours before sexual episode, prolongs IELT, increases the sense of control and sexual satisfaction in men of 18 to 64 years of age with PE. Since PE is associated with personal distress, interrelationship difficulty, dapoxetine provides help for men with PE to overcome this condition. 


Send your message to this manufacturer
Email:
Message:
Your message must be between 20-8000 characters
 

© 2015 - 2025, wfdbn.com All rights reserved.